May 2025 was a Great Month for Stocks up 6% so why aren’t you more bullish?…ASCO rally slows Update-2

UPDATE-2 6/4/25 215p...Merus (MRUS) announces pricing  of pubic offering should raise $300M at $57/sh, stock drops 7.3%. A great deal for the oncology Company to continue development of their  innovative, full-length multispecific antibodies and antibody drug conjugates (Biclonics®,...

Can Biotech Stocks Regain Momentum Amidst the Chaos?…Update-2…Risk off due to tariff whipsaw…

Update-2 5/3010a EDT..... WHIPSAWED. Changed course again after Trump comments on China roil markets-risk off. Renewed escalation in tensions with China. You have heard the magic word before "uncertainty".  Regeneron continues downward course after underwhelming results on a Phase  3 trial for...

With the Healthcare Sector in Turmoil Should You Rebalance Your Portfolio? Update-3…C’mon Back Biotech at ASCO!

Update-3 5/22-23..... 10:50a EDT....VIGL  continues to run on Sanofi acquisition.at $8/sh. Should spark our SMID biotech trading list but XBI is stuck at $78. Ahead of ASCO we should see more green shoots among SMID biotechs and soon some major news from oncology players like MERUS N.V.(MRUS)...

Pin It on Pinterest